These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 12741411)

  • 21. Walking the talk of trust in human subjects research: the challenge of regulating financial conflicts of interest.
    Gatter R
    Emory Law J; 2003; 52(1):327-401. PubMed ID: 15575096
    [No Abstract]   [Full Text] [Related]  

  • 22. New recommendations for protecting children as human research subjects.
    Maloney DM
    Hum Res Rep; 2004 Nov; 19(11):1-2. PubMed ID: 15675086
    [No Abstract]   [Full Text] [Related]  

  • 23. Conflict of interest in human subjects research.
    Groeger JS; Barnes M
    Crit Care Med; 2003 Mar; 31(3 Suppl):S137-42. PubMed ID: 12626959
    [No Abstract]   [Full Text] [Related]  

  • 24. Institutional review boards and financial conflict of interest.
    Maloney DM
    Hum Res Rep; 2001 May; 16(5):1-2. PubMed ID: 11833559
    [No Abstract]   [Full Text] [Related]  

  • 25. Children as research subjects: a proposal to revise the current federal regulations using a moral framework.
    Ross LF
    Stanford Law Pol Rev; 1997; 8(1):159-76. PubMed ID: 16528858
    [No Abstract]   [Full Text] [Related]  

  • 26. Research involving children: regulations, review boards and reform.
    Gandhi R
    J Health Care Law Policy; 2005; 8(2):264-330. PubMed ID: 16471026
    [No Abstract]   [Full Text] [Related]  

  • 27. IRBs and financial conflicts of interest.
    Maloney DM
    Hum Res Rep; 2002 Apr; 17(4):5. PubMed ID: 12374180
    [No Abstract]   [Full Text] [Related]  

  • 28. New requirements for vulnerable subjects and IRB membership.
    Maloney DM
    Hum Res Rep; 2000 Oct; 15(10):9. PubMed ID: 11917935
    [No Abstract]   [Full Text] [Related]  

  • 29. Conflict + interest: financial incentives and informed consent in human subject research.
    Benbow S
    Notre Dame J Law Ethics Public Policy; 2003; 17(1):181-215. PubMed ID: 14986653
    [No Abstract]   [Full Text] [Related]  

  • 30. Financial conflicts of interest are related to voting patterns at FDA Advisory Committee meetings.
    Lurie P
    MedGenMed; 2006 Oct; 8(4):22. PubMed ID: 17415305
    [No Abstract]   [Full Text] [Related]  

  • 31. Medical research oversight from the corporate governance perspective: comparing institutional review boards and corporate boards.
    Saver RS
    William Mary Law Rev; 2004 Nov; 46(2):619-730. PubMed ID: 17167924
    [No Abstract]   [Full Text] [Related]  

  • 32. Financial conflict of interest in medical research: overview and analysis of institutional controls.
    Henderson JA; Smith JJ
    Food Drug Law J; 2003; 58(2):251-67. PubMed ID: 12866557
    [No Abstract]   [Full Text] [Related]  

  • 33. AAMC Task Force issues first Financial Conflict of Interest Guidelines, and GAO urges HHS to reexamine financial conflict of interest guidance and regulations for NIH-funded research. Association of American Medical Colleges. U.S. General Accounting Office. Department of Health and Human Services.
    J Investig Med; 2002 Mar; 50(2):82-3. PubMed ID: 11928944
    [No Abstract]   [Full Text] [Related]  

  • 34. Taking the "I" out of IRB--and putting "community" in.
    Marshall MF
    Bioethics Forum; 2000; 16(4):7-12. PubMed ID: 11902185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of research on the decisionally impaired: history and gaps in the current regulatory system.
    Moreno JD
    J Health Care Law Policy; 1998; 1(1):1-21. PubMed ID: 15573427
    [No Abstract]   [Full Text] [Related]  

  • 36. Protecting subjects, preserving trust, promoting progress II: principles and recommendations for oversight of an institution's financial interests in human subjects research.
    AAMC Task Force on Financial Conflicts of Interest in Clinical Research
    Acad Med; 2003 Feb; 78(2):237-45. PubMed ID: 12584107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical trials. Proposed rules aim to curb financial conflicts of interest.
    Kaiser J
    Science; 2002 Jan; 295(5553):246-7. PubMed ID: 11786611
    [No Abstract]   [Full Text] [Related]  

  • 38. Regulating human gene therapy: legislative overreaction to human subject protection failures.
    Leavitt WJ
    Adm Law Rev; 2001; 53(1):315-41. PubMed ID: 16189905
    [No Abstract]   [Full Text] [Related]  

  • 39. NBAC recommendations on oversight of human subject research.
    Lo B; Groman M
    Seton Hall Law Rev; 2003; 32(3):493-512. PubMed ID: 12715803
    [No Abstract]   [Full Text] [Related]  

  • 40. Guidance on financial disclosure requirements.
    Maloney DM
    Hum Res Rep; 2001 May; 16(5):4. PubMed ID: 11833562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.